SCHEMBL367679

SCHEMBL367679

CCOC(=O)[C@H](N)CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL366162 1.00
SCHEMBL818996 1.00
Water SCHEMBL5917424 0.98 ALOX15 (0.44)
Hydrochloric Acid SCHEMBL1553115 0.98 ALOX15 (0.44)
SCHEMBL31615213 0.98 ALOX15 (0.44)
Hydrochloric Acid SCHEMBL593290 0.98 ALOX15 (0.44)
Hydrochloric Acid SCHEMBL4534897 0.98 ALOX15 (0.44)
Hydrochloric Acid SCHEMBL459507 0.98 ALOX15 (0.44)
Hydrochloric Acid SCHEMBL11223928 0.98 ALOX15 (0.44)
Hydrochloric Acid SCHEMBL16223251 0.95 ALOX15 (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 81 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109678811-B Asymmetric preparation method of florfenicol intermediate cyclic compound 湖北中牧安达药业有限公司 2020-12-29 CN claimed
EP-3113778-B1 PYRIDAZINE DERIVATIVES FOR USE IN THE PREVENTION OR TREATMENT OF AN ATAXIC DISORDER TAKEDA PHARMACEUTICALS CO (JP) 2018-06-06 EP claimed
US-20170014407-A1 PYRIDAZINE DERIVATIVES FOR USE IN THE PREVENTON OR TREATMENT OF AN ATAXIC DISORDER TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2017-01-19 US claimed
EP-3113778-A1 PYRIDAZINE DERIVATIVES FOR USE IN THE PREVENTION OR TREATMENT OF AN ATAXIC DISORDER Takeda Pharmaceutical Company Limited (JP) 2017-01-11 EP claimed
WO-2015132608-A1 PYRIDAZINE DERIVATIVES FOR USE IN THE PREVENTION OR TREATMENT OF AN ATAXIC DISORDER TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2015-09-11 WO claimed
WO-2025123013-A1 COMPOSITIONS FOR TREATING ADDICTION, DEPENDENCE, WITHDRAWAL, AND/OR OPIOID INDUCED HYPERALGESIA CASE WESTERN RESERVE UNIVERSITY (US) 2025-06-12 WO disclosed
WO-2025055882-A1 MB-102 RELATED COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF 杭州中美华东制药有限公司 2025-03-20 WO disclosed
CN-118908922-A Benzylphenyl ether compound containing benzofuran and benzothiophene, and preparation method and application thereof 广西大学 2024-11-08 CN disclosed
CN-118265699-A Asymmetric biphenyl derivative and preparation method and medical application thereof 西安新通药物研究股份有限公司 2024-06-28 CN disclosed
CN-115504973-B Benzisoxazole compound, preparation method, pharmaceutical composition and application thereof 中国医学科学院药物研究所 2024-05-14 CN disclosed
WO-2024088036-A1 ASYMMETRIC BIPHENYL DERIVATIVE, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF 西安新通药物研究股份有限公司 2024-05-02 WO disclosed
CN-117769543-A Method for preparing pyrazine carboxylic acid derivatives as fluorescent tracers 杭州中美华东制药有限公司 2024-03-26 CN disclosed
EP-1084704-A1 REMEDIES FOR SPINOCEREBELLAR ATAXIA AND COMPOSITIONS FOR TREATING SPINOCEREBELLAR ATAXIA MEIJI SEIKA KAISHA LTD. (JP) 2001-03-21 EP disclosed
WO-2000003739-A9 (CAG)/Q EXPANSION DISORDERS CORNELL RES FOUNDATION INC (US) 2000-11-02 WO disclosed
EP-1015479-A1 COMBINATORIAL LIBRARIES OF PEPTIDOMIMETIC MACROCYCLES AND PROCESSES THEREFOR ELI LILLY AND COMPANY (US) 2000-07-05 EP disclosed
WO-2000003739-A1 (CAG)/Q EXPANSION DISORDERS CORNELL RESEARCH FOUNDATION, INC. (US) 2000-01-27 WO disclosed
WO-1998046631-A1 COMBINATORIAL LIBRARIES OF PEPTIDOMIMETIC MACROCYCLES AND PROCESSES THEREFOR ELI LILLY AND COMPANY (US) 1998-10-22 WO disclosed
EP-0186292-B1 TRIPEPTIDES AND SWEETENING AGENTS CONTAINING THE SAME AJINOMOTO CO., INC. (JP) 1990-05-16 EP disclosed
US-4780528-A Tripeptides and sweetening agents containing the same AJINOMOTO CO., INC. (JP) 1988-10-25 US disclosed
EP-0186292-A2 Tripeptides and sweetening agents containing the same AJINOMOTO CO., INC. (JP) 1986-07-02 EP disclosed